For instance, in several tumors including lung and gastric cancers, PD-L1 expression evaluated by immunohistochemistry (IHC) is used as a crucial biomarker predicting response to anti-PD-1/PD-L1 agents11,12. The gene discussed is CD274; the disease is gastric cancer.